Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity

被引:0
作者
Muehlbacher, Axel [1 ,2 ,5 ,6 ]
Beaudet, Amelle [3 ]
Brand, Monika [3 ]
Janssen, Ellen M. [4 ]
Gunz, Holger [4 ]
Li, Wenjing [3 ]
Preiss, Michael [3 ]
Sadler, Andrew [2 ]
Disantostefano, Rachael L. [4 ]
机构
[1] Hsch Neubrandenburg, Hlth Econ & Hlth Care Management, Neubrandenburg, Germany
[2] Gesell Empir Beratung GmbH, Berlin, Germany
[3] Janssen Pharmaceut Co Johnson & Johnson, Actelion Pharmaceut Ltd, Allschwil, Switzerland
[4] Janssen Cilag Germany, Johnson & Johnson Pl, Neuss, North Rhine Wes, Germany
[5] Janssen Res & Dev LLC, Global Epidemiol, Titusville, NJ USA
[6] Gesell Empir Beratung GmbH, Hans Otto Str 30, D-10407 Berlin, Germany
关键词
best-worst scaling; latent class analysis; patient preferences; pulmonary arterial hypertension; DISCRETE-CHOICE EXPERIMENTS; CONJOINT-ANALYSIS APPLICATIONS; HEALTH; MODEL;
D O I
10.1016/j.jval.2023.10.012
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary circulation characterized by vascular remodeling that, if untreated, can lead to right heart dysfunction and death. This analysis measured heterogeneity in patient preferences for PAH-specific treatment regimens. Method: Adult patients with PAH with slight to marked limitations during physical activity were recruited through a patient organization in Germany. Participants completed an online best-worst scaling case 3 survey. Patients chose among 3 hypothetical treatment profiles defined by 6 benefits and risks at varying levels. Participants completed 12 choice tasks. Preference heterogeneity was assessed using latent class analysis. Results: A total of 83 participants (76% female) completed the survey. Best-fit model revealed 4 classes. Class 1 (19% of participants) assigned importance to multiple attributes particularly side effects, class 2 (34%) to physical activity limitations, class 3 (30%) to survival and physical activity limitations, and class 4 (17%) to survival. No differences in sociodemographic characteristics were observed across classes. Compared with other classes, class 4 was most likely to report having marked physical activity limitations (79%) and needing daily help (100%), while considering higher daily activity levels to be ordinary (walking >1 km [71%] or climbing several flights of stairs [50%]). Conclusion: This first patient preference study in a PAH population suggests that physical activity limitations in addition to survival matter most to patients; however, preference heterogeneity between groups of patients was observed. Patient preferences should be considered in treatment decision making to better balance patient's expectations regarding the known risk-benefit ratio of treatment.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 46 条
  • [1] Amaya-Amaya M, 2008, ECON NON-MARK GOOD, V11, P13
  • [2] [Anonymous], 2023, EUR HEART J, V44, P1312, DOI [10.1093/eurheartj/ehad005, 10.1093/eurheartj/ehac237]
  • [3] [Anonymous], Ngene 1.3 User Manual & Reference Guide. Australia2021
  • [4] [Anonymous], 2022, Sawtooth Software Lighthouse Studio Manual
  • [5] Effects coding in discrete choice experiments
    Bech, M
    Gyrd-Hansen, D
    [J]. HEALTH ECONOMICS, 2005, 14 (10) : 1079 - 1083
  • [6] Project Transform: engaging patient advocates to share their perspectives on improving research, treatment and policy
    Bridges, John F. P.
    Janssen, Ellen M.
    Ferris, Andrea
    Dy, Sydney M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1755 - 1762
  • [7] Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
    Bridges, John F. P.
    Hauber, A. Brett
    Marshall, Deborah
    Lloyd, Andrew
    Prosser, Lisa A.
    Regier, Dean A.
    Johnson, F. Reed
    Mauskopf, Josephine
    [J]. VALUE IN HEALTH, 2011, 14 (04) : 403 - 413
  • [8] Pulmonary Arterial Hypertension: Combination Therapy in Practice
    Burks, Marsha
    Stickel, Simone
    Galie, Nazzareno
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (04) : 249 - 257
  • [9] Sex- and Gender-Related Aspects in Pulmonary Hypertension
    D'Agostino, Anna
    Guindani, Paola
    Scaglione, Gerarda
    Di Vincenzo, Alessandra
    Tamascelli, Sara
    Spaggiari, Riccardo
    Salzano, Andrea
    D'Amuri, Andrea
    Marra, Alberto Maria
    Pilote, Louise
    Raparelli, Valeria
    [J]. HEART FAILURE CLINICS, 2023, 19 (01) : 11 - 24
  • [10] Degner L F, 1997, Can J Nurs Res, V29, P21